跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,496 条关于
“BRAF inhibitors”
全部
14,496
临床试验
6,926
药物
3,248
机构
10
资讯
4,312
去年
BRAF Inhibitors Show Promise in Treatment of Relapsed/Refractory Hairy Cell Leukemia
2个月前
Nuvectis In-Licenses Two Clinical-Stage Assets from Haisco, Transforming into Late-Stage Biopharma with Oral Factor B and Paradox-Breaker BRAF Inhibitors
去年
FORE Biotherapeutics Advances Plixorafenib in BRAF-Driven Tumors, Eyes Potential FDA Submission
3个月前
Molecular Glue Degraders of HuR Suppress BRAF-Mutant Colorectal Cancer
上个月
Labcorp's PGDx elio Tissue Complete CDx Gains FDA Approval as Companion Diagnostic for BRAF-Mutant Advanced Melanoma
去年
FORE Biotherapeutics Secures $38 Million in Series D-2 Financing to Advance Plixorafenib Clinical Trials
去年
ctDNA Monitoring Shows Promise in Stage III BRAF-Mutant Melanoma
去年
PD-1/PD-L1 Inhibitors Show Promise in Thyroid Cancer Treatment Through Combination Strategies
去年
FORE Biotherapeutics Reports Durable Clinical Benefit with Plixorafenib in BRAF-Altered Thyroid Cancers
2年前
C4 Therapeutics' CFT1946 Shows Promise in BRAF V600 Mutant Solid Tumors
第 1 页,共 432 页
上一页
下一页